Wright v. Barr

62 S.W.3d 509, 2001 Mo. App. LEXIS 1837, 2001 WL 1262324
CourtMissouri Court of Appeals
DecidedOctober 23, 2001
DocketWD 59067
StatusPublished
Cited by54 cases

This text of 62 S.W.3d 509 (Wright v. Barr) is published on Counsel Stack Legal Research, covering Missouri Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wright v. Barr, 62 S.W.3d 509, 2001 Mo. App. LEXIS 1837, 2001 WL 1262324 (Mo. Ct. App. 2001).

Opinion

THOMAS H. NEWTON, Judge.

W. Kent Barr, M.D., and Northland Cardiology, P.C. (“appellants”) appeal a jury verdict in favor of Mrs. Virginia Wright and Mr. John Wright (“respondents”). Respondents’ petition contained two counts. The first count alleged negligent treatment of Mrs. Wright’s atrial fibrillation, which caused her to suffer a stroke, and the second count was a loss of consortium claim brought by Mr. Wright. Appellants were found negligent in failing to have an echocardiogram performed pri- or to administering an electrocardioversion and in failing to provide anticoagulant medications to ensure that clotting did not exist in Mrs. Wright’s heart when electro-cardioversion was performed.

Appellants raise six points on appeal. In Point I, they claim that the trial court erred in denying appellants’ motion for directed verdict at the completion of respondents’ evidence because respondents failed to prove causation and, thus, did not make a submissible case. Next, Points II and III assert that the trial court erred in giving Instruction No. 5, respondents’ verdict director, because there was not substantial evidence to support the instruction. In Point IV, appellants argue that the trial court erred in allowing respondents’ counsel to engage in numerous improper arguments to the jury. Appellants’ fifth point asserts that the trial court erred in allowing the jury to award damages based on an exhibit prepared by respondents’ expert because respondents’ exhibit was based on matters not in evidence. Finally, appellants urge in their sixth point that the trial court erred in failing to conform the judgment pursuant to § 538.210, which places a cap on noneconomic damages.

We affirm.

I. Background

In 1991, Virginia Wright suffered a heart attack, which typically occurs when a blood clot severely or totally blocks one of the coronary arteries that supplies blood to the heart muscle. “Thrombolytics,” or clot busters, are the only medications currently available that can destroy an existing blood clot, and their use is reserved for the most extreme cases in which a clot is seriously obstructing blood flow to an area of the body, such as with a heart attack, stroke, or pulmonary embolism. To treat the heart attack, Mrs. Wright was given the clot buster “tissue plasminogen activa *516 tor” (“t-PA”), and she subsequently developed damage to her kidneys. It was unclear whether the damage was caused by a blood clot going to her kidney, or if she had hemorrhaged.

In 1996, Mrs. Wright suffered a stroke. She had suffered from “atrial fibrillation” for many years. Atrial fibrillation is a very common type of “arrhythmia,” which is an irregular heartbeat resulting from any change, deviation, or malfunction in the heart’s electrical system. Atrial fibrillation got its name because the atria, the heart’s upper chambers, quiver instead of contracting normally, resulting in an abnormally fast and highly irregular heartbeat.

Northland Cardiology is a general cardiology practice. The doctors there treat most cardiovascular problems, such as hypertension, congestive heart failure, and arrhythmias. They take care of patients with coronary artery disease and heart attack patients, and they recommend surgeries, procedures, and medications. In addition to atrial fibrillation, Mrs. Wright also suffered from hypertension and diabetes. With her heart problems, Mrs. Wright first became involved with North-land Cardiology by seeing Dr. James Ernest, who retired from the group in 1990. From 1990 through 1996, Mrs. Wright was seen at the Northland Cardiology office several times, and she was also seen at Trinity Lutheran Hospital by doctors from Northland Cardiology on at least two occasions. Dr. W. Kent Barr first became involved with Mrs. Wright’s care in 1994 when he performed a stress test on her.

To treat atrial fibrillation, oral calcium channel blockers (“CCBs”), such as cardiz-em or verapamil, may be used to slow the heart rate. If necessary, a doctor may treat a patient in atrial fibrillation by using paddles to apply an electric shock to the patient and convert the patient’s heart rhythm from atrial fibrillation to a normal rhythm, called sinus rhythm. This manner of restoring sinus rhythm is called “electrocardioversion” (“cardioversion”). 1 Prior to her heart attack in 1991, Mrs. Wright had cardioversion performed by a doctor at the VA Hospital in Leavenworth, Kansas. She was given the CCB vera-pamil, which, according to the attending physician, caused her heart to stop. The doctor performed cardioversion to restart her heart, and she was then transferred to KU Medical Center, where she remained for approximately ten days.

Atrial fibrillation is a powerful risk factor for stroke, making people with atrial fibrillation six times more likely to have a stroke than people without. Because the atria are quivering instead of contracting, the blood flow through the heart slows when a person is in atrial fibrillation. When blood starts pooling in the atria (“stasis”), there is a pronounced risk of blood clots forming. There are two situations in which the blood clots can cause serious problems. First, the clots can be dangerous if they are large enough to block a blood vessel where they have formed (“thrombus”). Second, if either a whole clot or pieces of the clot break off, the clot may travel through the bloodstream and block a blood vessel in another part of the body (“embolism”). Either scenario can result in a heart attack or stroke.

Most strokes are caused by a lack of or restricted blood flow to the brain (an “is-chemic stroke”), as opposed to by bleeding within or around the brain (a “hemorrhagic stroke”). An ischemic stroke results when brain does not get enough oxygen-rich blood, usually due to a blood clot that *517 is blocking an artery leading to the brain. The blood clot may have formed in an artery, causing a thrombotic stroke. Alternatively, a blood clot may have lodged in the artery after traveling through the bloodstream from another part of the body, which could cause an embolic stroke. A number of embolic strokes are a complication of stasis in the atria in people who have arrhythmias such as atrial fibrillation. In addition to atrial fibrillation, other risk factors for stroke include hypertension, diabetes, and bleeding disorders. These risk factors were present in Mrs. Wright.

On November 5,1996, Mrs. Wright went to the emergency room at Liberty Hospital in Liberty, Missouri. Dr. Barr noted that she had a long-standing history of paroxysmal atrial fibrillation, or atrial fibrillation that came and went, and an electrocardiogram confirmed that she was in the irregular rhythm of atrial fibrillation. Dr. Barr placed Mrs. Wright on cardizem to slow her heart rate. Because the risk of stroke associated with atrial fibrillation may be reduced through the use of “anticoagulants” by preventing new blood clots from forming and keeping existing clots from growing larger, Dr. Barr also placed her on intravenous “heparin” with the intention of admitting her to the hospital. Warfarin, sold under the brand name “Coumadin,” is the oral anticoagulant most frequently prescribed in cases of atrial fibrillation. While Coumadin takes several days to stop clots from forming, another type of anticoagulant, heparin, stops clotting almost immediately but only lasts for several hours. In addition, Mrs.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

William Miller-Kirkland v. State of Missouri
Missouri Court of Appeals, 2024
Bayes v. Biomet, Inc.
E.D. Missouri, 2020
Mona Brummett v. Burberry Limited
Missouri Court of Appeals, 2019
Southside Ventures, LLC v. La Crosse Lumber CO
Missouri Court of Appeals, 2019
Doe v. Belmar
564 S.W.3d 415 (Missouri Court of Appeals, 2018)
Love v. Waring
560 S.W.3d 614 (Missouri Court of Appeals, 2018)
Amie Wieland v. Owner-Operator Services, Inc.
Missouri Court of Appeals, 2016
Graham v. Latco Contractors, Inc.
456 S.W.3d 907 (Missouri Court of Appeals, 2015)
James R. Martin v. Division of Employment Security
460 S.W.3d 414 (Missouri Court of Appeals, 2015)
Janet Hurst v. Kansas City, Missouri School District
437 S.W.3d 327 (Missouri Court of Appeals, 2014)
Rouse v. CUVELIER
363 S.W.3d 406 (Missouri Court of Appeals, 2012)
Goltz v. Masten
333 S.W.3d 522 (Missouri Court of Appeals, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
62 S.W.3d 509, 2001 Mo. App. LEXIS 1837, 2001 WL 1262324, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wright-v-barr-moctapp-2001.